Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment

Recruiting now · Not applicable

Conditions studied: Hematologic Malignancy, Treatment Adherence, Treatment Complication, Frailty, Quality of Life

In brief

The Improve study is a randomized controlled trial investigating the efficacy of adding comprehensive geriatric assessment and treatment to standard of care compared with standard of care in older, frail patients with hematological cancer. The investigators aim to recruit 152 study participants who will be randomized 1:1 to intervention- or control group. Study participants in the intervention group will receive the intervention comprehensive geriatric assessment and treatment integrated in the cancer treatment. Study participants in the control group will receive cancer treatment and evaluation of comorbidity and frailty as is usual standard at Department of Hematology. Primary endpoint is elderly functional Index at 12 weeks.

Key facts

Study ID
NCT06373471
Run by
Odense University Hospital
People needed
152
Starts
2024-04-02
Expected to finish
2026-09-30
Last updated by the study team
2024-04-18

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.